Amy E Blain, Sema Mandal, Henry Wu, Jessica R MacNeil, Lee H Harrison, Monica M Farley, Ruth Lynfield, Lisa Miller, Megin Nichols, Sue Petit, Arthur Reingold, William Schaffner, Ann Thomas, Shelley M Zansky, Raydel Anderson, Brian H Harcourt, Leonard W Mayer, Thomas A Clark, Amanda C Cohn
In 2009, in the Active Bacterial Core surveillance sites, penicillin was not commonly used to treat meningococcal disease. This is likely because of inconsistent availability of antimicrobial susceptibility testing and ease of use of third-generation cephalosporins. Consideration of current practices may inform future meningococcal disease management guidelines.
September 2016: Open Forum Infectious Diseases